Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy in neuromuscular disease.

D S Younger1, N Raksadawan

  • 1Department of Neurology, New York University Medical Center and Lenox Hill Hospital, New York, USA.

Neurologic Clinics
|July 27, 2001
PubMed
Summary

This article details therapies for myasthenia gravis and inflammatory myopathy, highlighting significant advancements in treating neuromuscular diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic Acquired Demyelinating Polyneuropathy following Renal Transplantation.

Case reports in neurological medicine·2013
Same author

Motor disorders.

Journal of clinical neuromuscular disease·2008
Same author

Lyme neuroborreliosis.

Drugs of today (Barcelona, Spain : 1998)·2004
Same author

Diabetic peripheral neuropathy.

Drugs of today (Barcelona, Spain : 1998)·2004
Same author

Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson's disease.

Neuroscience·2002
Same author

Rapid detection of the two common mutations in Ashkenazi Jewish patients with mucolipidosis type IV.

Genetic testing·2001

Area of Science:

  • Neurology
  • Immunology

Background:

  • Myasthenia gravis and inflammatory myopathy are debilitating neuromuscular junction disorders.
  • Effective therapeutic strategies are crucial for managing disease progression and improving patient outcomes.

Purpose of the Study:

  • To provide a comprehensive overview of current therapeutic approaches for myasthenia gravis and inflammatory myopathy.
  • To underscore the progress in neuromuscular disease treatment.

Main Methods:

  • Literature review of established and emerging therapies.
  • Analysis of treatment efficacy and safety profiles.

Main Results:

  • Significant therapeutic advancements have been made in managing myasthenia gravis and inflammatory myopathy.
  • Current treatments offer improved disease control and quality of life for patients.

Conclusions:

  • The progress in treating these neuromuscular disorders exemplifies broader advancements in the field.
  • Continued research is essential for further refining therapeutic interventions.

Related Experiment Videos